Form 4: DarioHealth CEO Raphael Erez Increases Stake in Company
SEC Form 4 Filing
DarioHealth Corp. CEO Raphael Erez recently purchased 10,000 shares of common stock, signaling confidence in the company.
Summary
- Raphael Erez, the CEO of DarioHealth Corp., has reported changes in his beneficial ownership of the company's stock.
- On August 20, 2024, Erez purchased 5,000 shares of common stock at a price of $0.93 per share.
- On August 21, 2024, he purchased another 5,000 shares at $0.95 per share.
- Following these transactions, Erez directly owns 1,932,059 shares of DarioHealth Corp.
- He also indirectly owns 37,876 shares through Dicilyon Consulting and Investment Ltd.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive signal, but it's a relatively small amount compared to his existing holdings.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's prospects.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase as a positive sign.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Raphael Erez purchased 5,000 shares of common stock at $0.93 per share. |
| 08/21/2024 | Raphael Erez purchased 5,000 shares of common stock at $0.95 per share. |
| 08/23/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.